Showing results (21-30 of 45) with videos related to
Sort By:
Pageof 5
Cell Reports|March 19, 2020
Mapping Polyclonal Antibody Responses in Non-human Primates Vaccinated with HIV Env Trimer Subunit VaccinesBartek Nogal, Matteo Bianchi, Christopher A Cottrell, et al.Plos Pathogens|January 10, 2013
Recombinant HIV envelope proteins fail to engage germline versions of anti-CD4bs bNAbsSam Hoot, Andrew T McGuire, Kristen W Cohen, et al.Mucosal Immunology|January 19, 2023
Tissue-resident memory T cells trigger rapid exudation and local antibody accumulationPamela C Rosato, Sahar Lotfi-Emran, Vineet Joag, et al.Immunity|August 12, 2018
Electron-Microscopy-Based Epitope Mapping Defines Specificities of Polyclonal Antibodies Elicited during HIV-1 BG505 Envelope Trimer ImmunizationMatteo Bianchi, Hannah L Turner, Bartek Nogal, et al.Immunity|March 21, 2006
Natural IgE production in the absence of MHC Class II cognate helpKathy D McCoy, Nicola L Harris, Philipp Diener, et al.Science Translational Medicine|March 18, 2021
Effector function does not contribute to protection from virus challenge by a highly potent HIV broadly neutralizing antibody in nonhuman primatesLars Hangartner, David Beauparlant, Eva Rakasz, et al.Nature Immunology|August 10, 2004
Deliberate removal of T cell help improves virus-neutralizing antibody productionMike Recher, Karl S Lang, Lukas Hunziker, et al.Nature|September 7, 2007
Fc receptor but not complement binding is important in antibody protection against HIVAnn J Hessell, Lars Hangartner, Meredith Hunter, et al.Cell Reports|March 30, 2025
Molecular parameters governing antibody FcγR signaling and effector functions in the context of HIV envelopeMichael V Bick, Eduard Puig, David Beauparlant, et al.Nature Medicine|November 6, 2007
Extralymphatic virus sanctuaries as a consequence of potent T-cell activationMike Recher, Karl S Lang, Alexander Navarini, et al.Pageof 5